Skip to main content

Lee Chan Henry's Form 4 filing

BeOne Medicines Ltd. (ONC) · filed Jan 9, 2026

Accession no.
0001980648-26-000002
Filed
Jan 9, 2026
Trade date
Jan 7, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $220.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lee Chan HenryCIK 0001980648Officer (SVP, General Counsel)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 7, 2026American Depositary SharesMOption exerciseAcquired+202$194.47+$39,282.94202Direct
Jan 7, 2026American Depositary SharesMOption exerciseAcquired+266$213.32+$56,743.12468Direct
Jan 7, 2026American Depositary SharesMOption exerciseAcquired+196$159.03+$31,169.88664Direct
Jan 7, 2026American Depositary SharesSSaleDisposed−664$331.76−$220,288.640Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 7, 2026Ordinary SharesMOption exerciseDisposed−2,626$0.00$030,446Direct
Jan 7, 2026Ordinary SharesMOption exerciseDisposed−3,458$0.00$097,019Direct
Jan 7, 2026Ordinary SharesMOption exerciseDisposed−2,548$0.00$0118,118Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)